Sustainable Growth Advisers’s Novo Nordisk NVO Stock Holding History

Sustainable Growth Advisers’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,573	Closed	-$309K	–	57
2025 Q3	$309K	Sell	5,573 -6,187,063	-100%	-$362M	﹤0.01%	57
2025 Q2	$427M	Buy	6,192,636 +649,390	+12%	+$44.2M	2.21%	21
2025 Q1	$385M	Buy	5,543,246 +202,443	+4%	+$16.7M	2.15%	21
2024 Q4	$459M	Buy	5,340,803 +1,021,498	+24%	+$110M	2.3%	20
2024 Q3	$514M	Buy	4,319,305 +957,961	+28%	+$128M	2.18%	22
2024 Q2	$480M	Sell	3,361,344 -447,118	-12%	-$59.2M	2.12%	22
2024 Q1	$489M	Sell	3,808,462 -196,815	-5%	-$23.4M	2.05%	20
2023 Q4	$414M	Buy	4,005,277 +3,778,100	+1,663%	+$374M	1.89%	23
2023 Q3	$20.7M	Buy	227,177 +5,535	+2%	+$488K	0.11%	39
2023 Q2	$17.9M	Buy	221,642 +52,514	+31%	+$4.29M	0.09%	42
2023 Q1	$13.5M	Sell	169,128 -37,584	-18%	-$2.67M	0.08%	41
2022 Q4	$14M	Sell	206,712 -38,032	-16%	-$2.23M	0.09%	40
2022 Q3	$12.2M	Sell	244,744 -62,200	-20%	-$3.33M	0.09%	39
2022 Q2	$17.1M	Sell	306,944 -67,762	-18%	-$3.76M	0.12%	39
2022 Q1	$20.8M	Buy	374,706 +41,894	+13%	+$2.15M	0.12%	39
2021 Q4	$18.6M	Sell	332,812 -66,690	-17%	-$3.61M	0.1%	38
2021 Q3	$19.2M	Sell	399,502 -75,984	-16%	-$3.67M	0.1%	37
2021 Q2	$19.9M	Buy	475,486 +3,362	+0.7%	+$130K	0.1%	37
2021 Q1	$15.9M	Buy	472,124 +119,494	+34%	+$4.26M	0.09%	36
2020 Q4	$12.3M	Sell	352,630 -23,050	-6%	-$797K	0.08%	37
2020 Q3	$13M	Sell	375,680 -299,580	-44%	-$9.99M	0.09%	37
2020 Q2	$22.1M	Sell	675,260 -22,072	-3%	-$704K	0.16%	37
2020 Q1	$21M	Sell	697,332 -4,526,722	-87%	-$135M	0.23%	37
2019 Q4	$151M	Sell	5,224,054 -2,337,008	-31%	-$64.7M	1.42%	32
2019 Q3	$195M	Buy	7,561,062 +305,832	+4%	+$7.73M	1.96%	26
2019 Q2	$185M	Buy	7,255,230 +178,826	+3%	+$4.42M	1.9%	29
2019 Q1	$185M	Sell	7,076,404 -148,086	-2%	-$3.64M	2.05%	24
2018 Q4	$166M	Sell	7,224,490 -357,366	-5%	-$7.94M	2.15%	22
2018 Q3	$179M	Sell	7,581,856 -73,620	-1%	-$1.8M	1.99%	24
2018 Q2	$177M	Sell	7,655,476 -220,310	-3%	-$5.24M	2.1%	22
2018 Q1	$194M	Buy	7,875,786 +251,228	+3%	+$6.6M	2.3%	21
2017 Q4	$205M	Buy	7,624,558 +587,464	+8%	+$14.9M	2.4%	22
2017 Q3	$169M	Buy	7,037,094 +32,538	+0.5%	+$735K	2.31%	24
2017 Q2	$150M	Sell	7,004,556 -1,133,236	-14%	-$22.9M	2.2%	26
2017 Q1	$139M	Buy	8,137,792 +1,197,288	+17%	+$20.8M	2.37%	26
2016 Q4	$124M	Buy	6,940,504 +3,211,444	+86%	+$58.2M	2.48%	24
2016 Q3	$77.5M	Buy	3,729,060 +3,718,276	+34,480%	+$92.2M	1.46%	29
2016 Q2	$290K	Sell	10,784 -146,000	-93%	-$4M	0.01%	42
2016 Q1	$4.25M	Hold	156,784	–	–	0.09%	38
2015 Q4	$4.55M	Hold	156,784	–	–	0.1%	41
2015 Q3	$4.25M	Hold	156,784	–	–	0.09%	37
2015 Q2	$4.29M	Sell	156,784 -720	-0.5%	-$20.2K	0.09%	37
2015 Q1	$4.21M	Buy	157,504 +146,726	+1,361%	+$3.38M	0.1%	37
2014 Q4	$228K	Buy	10,778 +2,160	+25%	+$48.2K	0.01%	42
2014 Q3	$205K	Buy	+8,618	New	+$198K	﹤0.01%	58
2014 Q1	–	Sell	-3,830,340	Closed	-$70.8M	–	42
2013 Q4	$70.8M	Sell	3,830,340 -318,970	-8%	-$5.56M	1.53%	28
2013 Q3	$70.2M	Buy	4,149,310 +368,850	+10%	+$6.2M	1.55%	28
2013 Q2	$58.6M	Buy	+3,780,460	New	+$62.9M	1.46%	27

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sustainable Growth Advisers's NVO Position: Q4 2025 in Review

Sustainable Growth Advisers sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 5,573 shares — an estimated $309K sold.

Sustainable Growth Advisers first reported a position in NVO in Q2 2013 and held it in 48 quarters. The position peaked at $514M in Q3 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

Sustainable Growth Advisers reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
Sustainable Growth Advisers sold 5,573 Novo Nordisk shares in Q4 2025, an estimated $309K.
Sustainable Growth Advisers first reported a position in Novo Nordisk in Q2 2013 and held it in 48 quarters.
Sustainable Growth Advisers's Novo Nordisk position peaked at $514M in Q3 2024.
1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Sustainable Growth Advisers's 13F filing for Q4 2025, filed 10 Feb 2026.